SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients

References

• Lythgoe KA, Hall M, Ferretti L, et al. SARS-CoV-2 within-host diversity and transmission. Science. 2021;372(6539):6539.
   Web of Science ®Google Scholar
• Baric RS. Emergence of a highly fit SARS-CoV-2 variant. N Engl J Med. 2020;383(27):2684–2686.
   PubMed Web of Science ®Google Scholar
• Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):6538.
   Web of Science ®Google Scholar
• Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. 2021:2021.01.25.428137.
   Google Scholar
• Wang P, Casner RG, Nair MS, et al. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. 2021:2021.03.01.433466.
   Google Scholar
• Wang Y, Wang D, Zhang L, et al. Intra-Host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients. Genome Med. 2021;13(1):30.
   PubMed Web of Science ®Google Scholar
• Rahimi A, Mirzazadeh A, Tavakolpour S. Genetics and genomics of SARS-CoV-2: a review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection. Genomics. 2021 Jan;113(1 Pt 2):1221–1232.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Li H, Wu X, et al. Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol Biol. 2004;4(1):21.
   PubMed Web of Science ®Google Scholar
• Lam TT, Zhu H, Guan Y, et al. Genomic analysis of the emergence, evolution, and spread of human respiratory RNA viruses. Annu Rev Genomics Hum Genet. 2016;17(1):193–218.
   PubMedGoogle Scholar
• Wang D, Wang Y, Sun W, et al. Population bottlenecks and intra-host evolution during human-to-human transmission of SARS-CoV-2. Front Med (Lausanne). 2021;8:585358.
   PubMed Web of Science ®Google Scholar
• Kemp SA, Collier DA, Datir RP, et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592(7853):277–282. DOI:10.1038/s41586-021-03291-y.
   PubMed Web of Science ®Google Scholar
• Avanzato VA, Matson MJ, Seifert SN, et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell. 2020;183(7):1901–1912 e9.
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim SY, Kim TS, et al. Evidence of severe acute respiratory syndrome coronavirus 2 reinfection after recovery from mild coronavirus disease 2019. Clin Infect Dis. 2021;73(9):e3002–e3008.
   PubMedGoogle Scholar
• Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 2009;25(14):1754–1760.
   PubMed Web of Science ®Google Scholar
• CDC. Coronavirus disease 2019 (COVID-19): Discharging COVID-19 Patients. Atlanta (GA): US Department of Health and Human Services, CDC; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-patients.html
   Google Scholar
• Sequence Read Archive (SRA). Available from: https://www.ncbi.nlm.nih.gov/sra
   Google Scholar
• Global Initiative on Sharing All Influenza Data home page. [cited 2021 May 12]. Available from: https://www.gisaid.org/
   Google Scholar
• Sobel Leonard A, Weissman DB, Greenbaum B, et al. Transmission bottleneck size estimation from pathogen deep-sequencing data, with an application to human influenza a virus. J Virol. 2017;91(14). DOI:10.1128/JVI.00171-17.
   PubMed Web of Science ®Google Scholar
• Choi B, Choudhary MC, Regan J, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med. 2020;383(23):2291–2293.
   PubMed Web of Science ®Google Scholar
• Krause PR, Fleming TR, Longini IM, et al. SARS-CoV-2 variants and vaccines. N Engl J Med. 2021;385(2):179–186.
   PubMed Web of Science ®Google Scholar
• Boehm E, Kronig I, Neher RA, et al. Novel SARS-CoV-2 variants: the pandemics within the pandemic. Clin Microbiol Infect. 2021;27(8):1109–1117. DOI:10.1016/j.cmi.2021.05.022.
   PubMed Web of Science ®Google Scholar
• Singh J, Pandit P, McArthur AG, et al. Evolutionary trajectory of SARS-CoV-2 and emerging variants. Virol J. 2021;18(1):166.
   PubMed Web of Science ®Google Scholar
• Cherian S, Potdar V, Jadhav S, et al. SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India. Microorganisms. 2021;9(7):1542.
   PubMed Web of Science ®Google Scholar
• Starr TN, Greaney AJ, Hilton SK, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020;182(5):1295–1310 e20.
   PubMed Web of Science ®Google Scholar
• Focosi D, Maggi F. Neutralising antibody escape of SARS-CoV-2 spike protein: risk assessment for antibody-based Covid-19 therapeutics and vaccines. Rev Med Virol. 2021;31(6). DOI:10.1002/rmv.2231.
   Web of Science ®Google Scholar
• Jangra S, Ye C, Rathnasinghe R, et al. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe. 2021;2(7):e283–e284.
   PubMedGoogle Scholar
• Liu Z, VanBlargan LA, Bloyet LM, et al. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe. 2021;29(3):477–488 e4.
   PubMed Web of Science ®Google Scholar
• Park AK, Kim IH, Kim J, et al. Genomic surveillance of SARS-CoV-2: distribution of clades in the Republic of Korea in 2020. Osong Public Health Res Perspect. 2021;12(1):37–43. DOI:10.24171/j.phrp.2021.12.1.06.
   PubMedGoogle Scholar
• Sun J, Zhu A, Li H, et al. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg Microbes Infect. 2020;9(1):991–993. DOI:10.1080/22221751.2020.1760144.
   PubMed Web of Science ®Google Scholar
• Khan S, Chen L, Yang CR, et al. Does SARS-CoV-2 infect the kidney? J Am Soc Nephrol. 2020;31(12):2746–2748. DOI:10.1681/ASN.2020081229.
   PubMed Web of Science ®Google Scholar
• Puelles VG, Lutgehetmann M, Lindenmeyer MT, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590–592.
   PubMed Web of Science ®Google Scholar
• Farkash EA, Wilson AM, Jentzen JM. Ultrastructural evidence for direct renal infection with SARS-CoV-2. J Am Soc Nephrol. 2020 Aug;31(8):1683–1687.
   PubMed Web of Science ®Google Scholar
• Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1(6):e245–e253. DOI:10.1016/S2666-5247(20)30115-4.
   PubMed Web of Science ®Google Scholar